The Food and Drug Administration has issued a safety alert warning patients and caregivers about potential problems with some diabetes devices, such as continuous glucose monitors (CGMs), insulin pumps, and automated insulin dosing systems, which rely on smartphones to deliver critical safety alerts.
Apps for these devices allow users to configure settings for how and how often alerts are sent to their phones
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?